XML 22 R48.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Tables)
 12 Months Ended
Dec. 31, 2012
Segment Reporting, Measurement Disclosures [Abstract]  
Segment Results
Detailed segment data for the years ended December 31, 2012, 2011 and 2010 is presented in the following table ($ in millions):
 
 
2012
 
2011
 
2010
Total sales:
 
 
 
 
 
Test & Measurement
$
3,381.0

 
$
3,390.9

 
$
2,832.9

Environmental
3,063.5

 
2,939.6

 
2,738.0

Life Sciences & Diagnostics
6,485.1

 
4,627.4

 
2,298.3

Dental
2,022.9

 
2,011.2

 
1,824.6

Industrial Technologies
3,307.9

 
3,121.4

 
2,540.6

Businesses contributed to Apex joint venture attributable to periods prior to contribution
—

 
—

 
315.6

 
$
18,260.4

 
$
16,090.5

 
$
12,550.0

Operating profit:
 
 
 
 
 
Test & Measurement
$
701.2

 
$
751.2

 
$
572.9

Environmental
652.5

 
622.7

 
564.3

Life Sciences & Diagnostics
861.1

 
402.3

 
227.9

Dental
293.1

 
236.1

 
203.3

Industrial Technologies
685.6

 
655.0

 
513.3

Businesses contributed to Apex joint venture:
 
 
 
 
 
Attributable to periods prior to contribution
—

 
—

 
41.5

Equity method earnings subsequent to joint venture formation
69.9

 
66.8

 
22.8

Other
(98.3
)
 
(116.9
)
 
(96.4
)
 
$
3,165.1

 
$
2,617.2

 
$
2,049.6

Identifiable assets (including assets held for sale):
 
 
 
 
 
Test & Measurement
$
5,505.8

 
$
5,280.6

 
$
5,322.9

Environmental
3,146.6

 
2,784.8

 
2,634.9

Life Sciences & Diagnostics
13,305.2

 
12,888.4

 
4,071.7

Dental
4,079.9

 
4,047.5

 
4,120.2

Industrial Technologies
4,235.6

 
3,394.9

 
2,876.8

Other
2,667.9

 
1,553.3

 
3,190.6

 
$
32,941.0

 
$
29,949.5

 
$
22,217.1

Depreciation and amortization:
 
 
 
 
 
Test & Measurement
$
132.3

 
$
126.6

 
$
107.7

Environmental
48.9

 
45.9

 
45.9

Life Sciences & Diagnostics
478.2

 
297.2

 
90.7

Dental
92.4

 
94.0

 
81.7

Industrial Technologies
80.8

 
65.8

 
51.5

Businesses contributed to Apex joint venture attributable to periods prior to contribution
—

 
—

 
6.2

Other
7.2

 
5.5

 
4.6

 
$
839.8

 
$
635.0

 
$
388.3

 
2012
 
2011
 
2010
Capital expenditures, gross
 
 
 
 
 
Test & Measurement
$
37.5

 
$
37.7

 
$
35.6

Environmental
29.5

 
29.1

 
25.4

Life Sciences & Diagnostics
296.8

 
167.0

 
49.6

Dental
30.2

 
35.4

 
31.8

Industrial Technologies
49.0

 
51.3

 
35.4

Businesses contributed to Apex joint venture attributable to periods prior to contribution
—

 
—

 
6.9

Other
15.3

 
14.0

 
6.4

 
$
458.3

 
$
334.5

 
$
191.1
Schedule Of Operations In Geographical Areas
Operations in Geographical Areas
Year Ended December 31
 
($ in millions)
2012
 
2011
 
2010
Sales:
 
 
 
 
 
United States
$
7,809.8

 
$
6,787.8

 
$
5,703.3

Germany
1,111.3

 
1,189.0

 
928.9

China
1,443.5

 
1,133.2

 
748.7

Japan
892.8

 
809.4

 
603.0

All other (each country individually less than 5% of total sales)
7,003.0

 
6,171.1

 
4,566.1

 
$
18,260.4

 
$
16,090.5

 
$
12,550.0

Long-lived assets (Including assets held for sale):
 
 
 
 
 
United States
$
15,980.8

 
$
16,433.0

 
$
9,979.4

Germany
1,957.1

 
1,455.8

 
1,398.9

All other (each country individually less than 5% of total long-lived assets)
7,415.3

 
5,788.3

 
4,773.4

 
$
25,353.2

 
$
23,677.1

 
$
16,151.7
Sales By Major Product Group
Sales by Major Product Group
Year Ended December 31
 
($ in millions)
2012
 
2011
 
2010
Analytical and physical instrumentation
$
6,000.8

 
$
5,920.9

 
$
5,206.0

Medical & dental products
8,509.1

 
6,653.5

 
4,122.9

Motion and industrial automation controls
1,592.4

 
1,677.1

 
1,517.7

Mechanics and related hand tools
330.5

 
305.2

 
590.9

Product identification
1,410.3

 
1,162.1

 
818.4

All other
417.3

 
371.7

 
294.1

 
$
18,260.4

 
$
16,090.5

 
$
12,550.0